RightAnswer Knowledge Solutions Search Results for 201530-41-8

RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.

A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.

---

RightAnswer Proprietary Data Sources:

---

All Other Data Sources:

---

ChemID External Links:

---

Other Government Links Searched via RegsKnowledge:

Example Content from MEDITEXT for 201530-41-8:

Please note: this is an extract of information from a larger document. Full document and details are available by subscription.

ACUTE EXPOSURE INFORMATION

1. WITH THERAPEUTIC USE
   1. Adverse effects reported with the use of deferasirox included the following: increased serum creatinine, proteinuria, acute renal failure, increased ALT, drug-induced hepatitis, cytopenias (agranulocytosis, neutropenia, thrombocytopenia) rash, urticaria, abdominal pain, nausea, vomiting, diarrhea, back and joint pain, headache, fatigue.

2. WITH POISONING/EXPOSURE
   1. Hepatitis was reported in one patient who received 2 to 3 times the prescribed dose of deferasirox over a period of several weeks. In iron overloaded beta-thalassemic patients, single doses up to 80 mg/kg have been tolerated with nausea and diarrhea noted. Single doses up to 40 mg/kg were tolerated in healthy volunteers.

© 2011-2025 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.